Advertisement
Document › Details
AB Sciex (d/b/a Sciex). (1/23/18). "Press Release: Sciex Launches High-performance Mass Spectrometry Technology that Brings Ultimate Sensitivity and Speed to Clinical Diagnostics Laboratories". Framingham, MA.
The SCIEX Citrine™ MS/MS medical device provides clinical labs with one solution to tackle today’s difficult assays, and the versatility to address tomorrow’s precision medicine and wellness testing
SCIEX Diganostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today the launch of the Citrine™ Triple Quad™ MS/MS and Citrine™ QTRAP® MS/MS Systems for clinical diagnostics. The Citrine System is designed specifically to meet the unique needs of clinical labs that require maximum sensitivity, the highest throughput, a wide dynamic range, and the ability to employ simplified sample preparation.
The unique combination of sensitivity and speed offered by the Citrine MS/MS system makes this the ideal choice for the clinical laboratory, enabling trace level analysis, comprehensive panels, and the measurement of both large and small molecules. Triple quadrupole and QTRAP models of the system are available, each offering ultimate sensitivity to enable the measurement of metabolites and biomarkers at picomole concentrations. In addition, the exclusive QTRAP technology enables unique workflows, providing quantitative and qualitative analysis in a single injection, and allowing the use of highly selective MRM3 quantitation to eliminate interferences.
The system is powered by the familiar Analyst®MD software, for intuitive instrument control and data processing. The second generation IonDrive™ Turbo V ionization source provides robust, reliable performance when analyzing even the most complex biological samples, maximizes uptime, and enables the use of simpler sample preparation strategies
"The Citrine MS/MS system delivers the legendary robustness and reliability of a SCIEX mass spectrometry solution, but also provides clinical laboratories with the necessary performance to address the most challenging clinical applications" said Dr. Aaron Hudson, Vice President and GM of SCIEX Diagnostics. "The speed and sensitivity of the system translate into meaningful advantages for our customers, who are always trying to do more with less. Not only can clinical labs expand their capabilities by bringing testing in-house and developing their own lab developed tests (LDT), they can also achieve faster run-times, develop highly multiplexed panels to increase laboratory efficiency, and take advantage of simplified sample preparation to reduce costs and labor."
The system offers electrospray ionization (ESI) and atmospheric chemical ionization (APCI) options, an extended mass range up to m/z 2000, and a wide linear dynamic range, making this a versatile tool for the measurement of a large variety of polar and non-polar biomarkers and metabolites in biological fluids, over a large range of concentrations.
"Reliable quantitative measurement of trace level compounds such as steroidal hormones is extremely difficult. While traditional immunological methods offer high sensitivity, they rely on the selectivity of the antibody used and are prone to misidentification," said Dr. Rao Maddipatti, Associate Professor and Director, Lipidomics Core Facility, Wayne State University. "Mass spectrometric quantification alleviates such concerns of selectivity. With the ultra-sensitive Citrine MS/MS system, not only can these trace level steroids be measured with confidence, but the analyses can also multiplex over a hundred compounds in a single experiment, allowing clinicians and patients to benefit from a bird's eye view of the metabolome."
de novo pathway) LC-MS based Vitamin D kit was recently released for exclusive use with the Topaz system.
To learn more about the SCIEX Citrine System: view our website at sciex.com/diagnostics, visit the Sciex booth (#12-13) at MSACL, or attend our workshop at MSACL.
Disclaimer: Product not currently available for sale pending registration and listing in the US and EC marking for EU
About SCIEX
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.
With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please go to sciex.com
SCIEX social: Twitter, LinkedIn, and on Facebook.
For research use only. Not for use in diagnostic procedures. IVD-MKT-12-7212-A
AB Sciex is operating as SCIEX.
© 2018 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.
Contact Information
Sean Iverson
Global Marketing Director
sean.iverson@sciex.com
(508) 383-7146
Editorial follow-up
Kate Whelan
Notch Communications on Behalf of SCIEX
kate.wheland@notchcommunications.co.uk
+44 161 457 7230/ +46 702 381149
###
Record changed: 2023-06-05 |
Advertisement
More documents for Danaher (Group)
- [1] Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.....
- [2] Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC....
- [3] Molecular Devices, LLC. (2/7/23). "Press Release: Molecular Devices Partners with Seed Biosciences to Exclusively Offer DispenCell Single-Cell Dispenser, Expanding Leadership in Cell Line Development". San José, CA....
- [4] Refeyn Ltd.. (1/23/23). "Press Release: Refeyn Appoints Interim CEO"....
- [5] Molecular Devices, LLC. (1/4/23). "Press Release: Molecular Devices and Advanced Solutions Life Sciences Collaborate to Develop 3D Biology Automation Technologies for Drug Discovery". San José, CA....
- [6] Molecular Devices, LLC. (12/6/22). "Press Release: Molecular Devices Adds Proprietary Patient-derived Organoid Technology with Acquisition of Cellesce". San José, CA & Cardiff....
- [7] Cytiva. (10/6/22). "Press Release: Cytiva Strengthens Cell Line Development with Cevec Acquisition"....
- [8] Beckman Coulter Life Sciences. (9/13/22). "Press Release: ValitaCell Joins Beckman Coulter Life Sciences". Indianapolis, IN & Dublin....
- [9] HeartBeat.bio AG. (9/12/22). "Press Release: HeartBeat.bio and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA....
- [10] AB Sciex (d/b/a Sciex). (11/1/21). "Press Release: Sciex and Evosep Will Collaborate to Provide Robust, High-throughput Proteomics Workflows"....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top